Category Archives: Press Releases

Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combined

Q1-2023 product revenues approximately $0.76M exceeded the $0.66M combined revenue of Q3+Q4 2022 NEW HAVEN, [...]

Precipio Announces 2022 Fourth Quarter and Year-End Shareholder Update Call

Conference Call to be held on Monday, April 3rd, 2023 at 5:00 PM EST NEW [...]

Precipio Ships First IV-Cell® Order to Major US Healthcare System

Products Division revenues begin to diversify beyond HemeScreen® NEW HAVEN, CT, Globenewswire – (March 21st, [...]

Precipio continues to sign up and onboard HemeScreen™ customers

Conversion from sales funnels developed with distribution partners alongside direct sales points to continued accelerated [...]

Precipio’s HemeScreen® Selected as 2022 Best New Product

HemeScreen® Technology and Product Line were recognized by Fisher Healthcare during recent National Sales Meeting [...]

Precipio Signs Another Major HemeScreen™ Customer

Customer’s initial annual revenue expected at $650K, $2.0M revenue at full capacity NEW HAVEN, CT, [...]

Precipio Signs Additional Major HemeScreen™ Customer

Customer to begin gradually onboarding panels in Q1-2023, potential $1.2M revenue at full capacity NEW [...]

Precipio Presents Poster on HemeScreen® Study at Association of Molecular Pathology (AMP) 2022 Annual Conference

Poster presents findings of a study of ~1000 patient samples demonstrating superior accuracy for HemeScreen™ [...]

Precipio Announces Third Quarter Shareholder Update Call

Conference Call to be held on Monday, November 14th, 2022 at 5:00 PM ET NEW [...]

Precipio Signs Agreement with Another Major US Healthcare Distributor for HemeScreen™

Adding customer segment exceeding $100M in market potential NEW HAVEN, CT, Globenewswire – (September 15th, [...]